Exact Mass: 881.6896876

PE(22:2(13Z,16Z)/24:1(15Z))

C51H96NO8P (881.6873185999999)

PE(22:2(13Z,16Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:2(13Z,16Z)/24:1(15Z)), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(24:1(15Z)/22:2(13Z,16Z))

C51H96NO8P (881.6873185999999)

PE(24:1(15Z)/22:2(13Z,16Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/22:2(13Z,16Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PC(O-22:0/22:3(10Z,13Z,16Z))

C52H100NO7P (881.723702)

PC(O-22:0/22:3(10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-22:0/22:3(10Z,13Z,16Z)), in particular, consists of one chain of Behenyl alcohol at the C-1 position and one chain of (10Z,13Z,16Z-docosatrienoyl) at the C-2 position. The Behenyl alcohol moiety is derived from Rice bran, while the (10Z,13Z,16Z-docosatrienoyl) moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-22:0/22:3(10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-22:0/22:3(10Z,13Z,16Z)), in particular, consists of one chain of Behenyl alcohol at the C-1 position and one chain of (10Z,13Z,16Z-docosatrienoyl) at the C-2 position. The Behenyl alcohol moiety is derived from Rice bran, while the (10Z,13Z,16Z-docosatrienoyl) moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(O-22:1(13Z)/22:2(13Z,16Z))

C52H100NO7P (881.723702)

PC(O-22:1(13Z)/22:2(13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-22:1(13Z)/22:2(13Z,16Z)), in particular, consists of one chain of Erucyl alcohol at the C-1 position and one chain of docosadienoic acid at the C-2 position. The Erucyl alcohol moiety is derived from Rapeseed oil, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-22:1(13Z)/22:2(13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-22:1(13Z)/22:2(13Z,16Z)), in particular, consists of one chain of Erucyl alcohol at the C-1 position and one chain of docosadienoic acid at the C-2 position. The Erucyl alcohol moiety is derived from Rapeseed oil, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe2(20:2(11Z,14Z)/24:1(15Z))

C51H96NO8P (881.6873185999999)

PE-NMe2(20:2(11Z,14Z)/24:1(15Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:2(11Z,14Z)/24:1(15Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:3(5Z,8Z,11Z)/24:0)

C51H96NO8P (881.6873185999999)

PE-NMe2(20:3(5Z,8Z,11Z)/24:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:3(5Z,8Z,11Z)/24:0), in particular, consists of one chain of mead acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:3(8Z,11Z,14Z)/24:0)

C51H96NO8P (881.6873185999999)

PE-NMe2(20:3(8Z,11Z,14Z)/24:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:3(8Z,11Z,14Z)/24:0), in particular, consists of one chain of dihomo-gamma-linolenic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:1(13Z)/22:2(13Z,16Z))

C51H96NO8P (881.6873185999999)

PE-NMe2(22:1(13Z)/22:2(13Z,16Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:1(13Z)/22:2(13Z,16Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:2(13Z,16Z)/22:1(13Z))

C51H96NO8P (881.6873185999999)

PE-NMe2(22:2(13Z,16Z)/22:1(13Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:2(13Z,16Z)/22:1(13Z)), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(24:0/20:3(5Z,8Z,11Z))

C51H96NO8P (881.6873185999999)

PE-NMe2(24:0/20:3(5Z,8Z,11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:0/20:3(5Z,8Z,11Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of mead acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(24:0/20:3(8Z,11Z,14Z))

C51H96NO8P (881.6873185999999)

PE-NMe2(24:0/20:3(8Z,11Z,14Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:0/20:3(8Z,11Z,14Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of dihomo-gamma-linolenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(24:1(15Z)/20:2(11Z,14Z))

C51H96NO8P (881.6873185999999)

PE-NMe2(24:1(15Z)/20:2(11Z,14Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:1(15Z)/20:2(11Z,14Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PC(22:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C50H92NO9P (881.6509351999999)

PC(22:0/20:3(5Z,8Z,11Z)-O(14R,15S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:3(5Z,8Z,11Z)-O(14R,15S)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 14,15-epoxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(5Z,8Z,11Z)-O(14R,15S)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:3(5Z,8Z,11Z)-O(14R,15S)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(5Z,8Z,11Z)-O(14R,15S)/22:0), in particular, consists of one chain of one 14,15-epoxyeicosatrienoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C50H92NO9P (881.6509351999999)

PC(22:0/20:3(5Z,8Z,14Z)-O(11S,12R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:3(5Z,8Z,14Z)-O(11S,12R)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 11,12-epoxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(5Z,8Z,14Z)-O(11S,12R)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:3(5Z,8Z,14Z)-O(11S,12R)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(5Z,8Z,14Z)-O(11S,12R)/22:0), in particular, consists of one chain of one 11,12-epoxyeicosatrienoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:3(5Z,11Z,14Z)-O(8,9))

C50H92NO9P (881.6509351999999)

PC(22:0/20:3(5Z,11Z,14Z)-O(8,9)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:3(5Z,11Z,14Z)-O(8,9)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 8,9--epoxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(5Z,11Z,14Z)-O(8,9)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:3(5Z,11Z,14Z)-O(8,9)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(5Z,11Z,14Z)-O(8,9)/22:0), in particular, consists of one chain of one 8,9--epoxyeicosatrienoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:3(8Z,11Z,14Z)-O(5,6))

C50H92NO9P (881.6509351999999)

PC(22:0/20:3(8Z,11Z,14Z)-O(5,6)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:3(8Z,11Z,14Z)-O(5,6)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 5,6-epoxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(8Z,11Z,14Z)-O(5,6)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:3(8Z,11Z,14Z)-O(5,6)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(8Z,11Z,14Z)-O(5,6)/22:0), in particular, consists of one chain of one 5,6-epoxyeicosatrienoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(20)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 20-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(20)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(20)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(20)/22:0), in particular, consists of one chain of one 20-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(6E,8Z,11Z,14Z)-OH(5S)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 5-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(6E,8Z,11Z,14Z)-OH(5S)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(6E,8Z,11Z,14Z)-OH(5S)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(6E,8Z,11Z,14Z)-OH(5S)/22:0), in particular, consists of one chain of one 5-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 19-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(19S)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(19S)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(19S)/22:0), in particular, consists of one chain of one 19-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 18-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(18R)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(18R)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(18R)/22:0), in particular, consists of one chain of one 18-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(17)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 17-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(17)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(17)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(17)/22:0), in particular, consists of one chain of one 17-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 16-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(16R)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(16R)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(16R)/22:0), in particular, consists of one chain of one 16-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(5Z,8Z,11Z,13E)-OH(15S)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 15-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,13E)-OH(15S)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,13E)-OH(15S)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,13E)-OH(15S)/22:0), in particular, consists of one chain of one 15-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(5Z,8Z,10E,14Z)-OH(12S)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 12-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,10E,14Z)-OH(12S)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,10E,14Z)-OH(12S)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,10E,14Z)-OH(12S)/22:0), in particular, consists of one chain of one 12-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(5E,8Z,12Z,14Z)-OH(11R)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 11-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5E,8Z,12Z,14Z)-OH(11R)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(5E,8Z,12Z,14Z)-OH(11R)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5E,8Z,12Z,14Z)-OH(11R)/22:0), in particular, consists of one chain of one 11-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,7E,11Z,14Z)-OH(9)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:4(5Z,7E,11Z,14Z)-OH(9)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 9-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,7E,11Z,14Z)-OH(9)/22:0)

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,7E,11Z,14Z)-OH(9)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,7E,11Z,14Z)-OH(9)/22:0), in particular, consists of one chain of one 9-Hydroxyeicosatetraenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:1(13Z)/20:3(6,8,11)-OH(5))

C50H92NO9P (881.6509351999999)

PC(22:1(13Z)/20:3(6,8,11)-OH(5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:1(13Z)/20:3(6,8,11)-OH(5)), in particular, consists of one chain of one 13Z-docosenoyl at the C-1 position and one chain of 5-hydroxyeicosatetrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(6,8,11)-OH(5)/22:1(13Z))

C50H92NO9P (881.6509351999999)

PC(20:3(6,8,11)-OH(5)/22:1(13Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(6,8,11)-OH(5)/22:1(13Z)), in particular, consists of one chain of one 5-hydroxyeicosatetrienoyl at the C-1 position and one chain of 13Z-docosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:1(15Z)/18:2(10E,12Z)+=O(9))

C50H92NO9P (881.6509351999999)

PC(24:1(15Z)/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:1(15Z)/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one 15Z-tetracosenoyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:2(10E,12Z)+=O(9)/24:1(15Z))

C50H92NO9P (881.6509351999999)

PC(18:2(10E,12Z)+=O(9)/24:1(15Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:2(10E,12Z)+=O(9)/24:1(15Z)), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of 15Z-tetracosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:1(15Z)/18:2(9Z,11E)+=O(13))

C50H92NO9P (881.6509351999999)

PC(24:1(15Z)/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:1(15Z)/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one 15Z-tetracosenoyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:2(9Z,11E)+=O(13)/24:1(15Z))

C50H92NO9P (881.6509351999999)

PC(18:2(9Z,11E)+=O(13)/24:1(15Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:2(9Z,11E)+=O(13)/24:1(15Z)), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of 15Z-tetracosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:1(15Z)/18:3(10,12,15)-OH(9))

C50H92NO9P (881.6509351999999)

PC(24:1(15Z)/18:3(10,12,15)-OH(9)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:1(15Z)/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one 15Z-tetracosenoyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:3(10,12,15)-OH(9)/24:1(15Z))

C50H92NO9P (881.6509351999999)

PC(18:3(10,12,15)-OH(9)/24:1(15Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:3(10,12,15)-OH(9)/24:1(15Z)), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of 15Z-tetracosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:1(15Z)/18:3(9,11,15)-OH(13))

C50H92NO9P (881.6509351999999)

PC(24:1(15Z)/18:3(9,11,15)-OH(13)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:1(15Z)/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one 15Z-tetracosenoyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:3(9,11,15)-OH(13)/24:1(15Z))

C50H92NO9P (881.6509351999999)

PC(18:3(9,11,15)-OH(13)/24:1(15Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:3(9,11,15)-OH(13)/24:1(15Z)), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of 15Z-tetracosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PE(46:3)

C51H96NO8P (881.6873185999999)

PC O-44:3

C52H100NO7P (881.723702)

PC(22:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C50H92NO9P (881.6509351999999)

PC(20:3(5Z,8Z,11Z)-O(14R,15S)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C50H92NO9P (881.6509351999999)

PC(20:3(5Z,8Z,14Z)-O(11S,12R)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:3(5Z,11Z,14Z)-O(8,9))

C50H92NO9P (881.6509351999999)

PC(20:3(5Z,11Z,14Z)-O(8,9)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:3(8Z,11Z,14Z)-O(5,6))

C50H92NO9P (881.6509351999999)

PC(20:3(8Z,11Z,14Z)-O(5,6)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(20)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C50H92NO9P (881.6509351999999)

PC(20:4(6E,8Z,11Z,14Z)-OH(5S)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(19S)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(18R)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(17)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(16R)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,11Z,13E)-OH(15S)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,8Z,10E,14Z)-OH(12S)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C50H92NO9P (881.6509351999999)

PC(20:4(5E,8Z,12Z,14Z)-OH(11R)/22:0)

C50H92NO9P (881.6509351999999)

PC(22:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C50H92NO9P (881.6509351999999)

PC(20:4(5Z,7E,11Z,14Z)-OH(9)/22:0)

C50H92NO9P (881.6509351999999)

PC(24:1(15Z)/18:2(10E,12Z)+=O(9))

C50H92NO9P (881.6509351999999)

PC(18:2(10E,12Z)+=O(9)/24:1(15Z))

C50H92NO9P (881.6509351999999)

PC(24:1(15Z)/18:2(9Z,11E)+=O(13))

C50H92NO9P (881.6509351999999)

PC(18:2(9Z,11E)+=O(13)/24:1(15Z))

C50H92NO9P (881.6509351999999)

PC(22:1(13Z)/20:3(6,8,11)-OH(5))

C50H92NO9P (881.6509351999999)

PC(20:3(6,8,11)-OH(5)/22:1(13Z))

C50H92NO9P (881.6509351999999)

PC(24:1(15Z)/18:3(10,12,15)-OH(9))

C50H92NO9P (881.6509351999999)

PC(18:3(10,12,15)-OH(9)/24:1(15Z))

C50H92NO9P (881.6509351999999)

PC(24:1(15Z)/18:3(9,11,15)-OH(13))

C50H92NO9P (881.6509351999999)

PC(18:3(9,11,15)-OH(13)/24:1(15Z))

C50H92NO9P (881.6509351999999)

HexCer 8:1;2O/40:7

C54H91NO8 (881.6744326)

HexCer 8:0;2O/40:8

C54H91NO8 (881.6744326)

HexCer 16:0;2O/32:8

C54H91NO8 (881.6744326)

HexCer 14:2;2O/34:6

C54H91NO8 (881.6744326)

HexCer 10:1;2O/38:7

C54H91NO8 (881.6744326)

HexCer 16:2;2O/32:6

C54H91NO8 (881.6744326)

HexCer 20:3;2O/28:5

C54H91NO8 (881.6744326)

HexCer 18:1;2O/30:7

C54H91NO8 (881.6744326)

HexCer 18:0;2O/30:8

C54H91NO8 (881.6744326)

HexCer 12:1;2O/36:7

C54H91NO8 (881.6744326)

HexCer 30:3;2O/18:5

C54H91NO8 (881.6744326)

HexCer 24:3;2O/24:5

C54H91NO8 (881.6744326)

HexCer 14:0;2O/34:8

C54H91NO8 (881.6744326)

HexCer 24:2;2O/24:6

C54H91NO8 (881.6744326)

HexCer 26:3;2O/22:5

C54H91NO8 (881.6744326)

HexCer 10:0;2O/38:8

C54H91NO8 (881.6744326)

HexCer 18:3;2O/30:5

C54H91NO8 (881.6744326)

HexCer 20:1;2O/28:7

C54H91NO8 (881.6744326)

HexCer 20:2;2O/28:6

C54H91NO8 (881.6744326)

HexCer 14:1;2O/34:7

C54H91NO8 (881.6744326)

HexCer 22:1;2O/26:7

C54H91NO8 (881.6744326)

HexCer 18:2;2O/30:6

C54H91NO8 (881.6744326)

HexCer 16:1;2O/32:7

C54H91NO8 (881.6744326)

HexCer 28:3;2O/20:5

C54H91NO8 (881.6744326)

HexCer 12:2;2O/36:6

C54H91NO8 (881.6744326)

HexCer 22:2;2O/26:6

C54H91NO8 (881.6744326)

HexCer 14:3;2O/34:5

C54H91NO8 (881.6744326)

HexCer 22:3;2O/26:5

C54H91NO8 (881.6744326)

HexCer 16:3;2O/32:5

C54H91NO8 (881.6744326)

HexCer 12:0;2O/36:8

C54H91NO8 (881.6744326)

HexCer 26:2;2O/22:6

C54H91NO8 (881.6744326)

[3-hexadecoxy-2-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

HexCer 17:2;2O/28:1;2O

C51H95NO10 (881.695561)

HexCer 14:2;2O/31:1;2O

C51H95NO10 (881.695561)

HexCer 14:1;2O/31:2;2O

C51H95NO10 (881.695561)

HexCer 16:1;2O/29:2;2O

C51H95NO10 (881.695561)

HexCer 15:1;2O/30:2;2O

C51H95NO10 (881.695561)

HexCer 16:2;2O/29:1;2O

C51H95NO10 (881.695561)

HexCer 17:1;2O/28:2;2O

C51H95NO10 (881.695561)

HexCer 15:2;2O/30:1;2O

C51H95NO10 (881.695561)

2-[2-[(15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-15,18,21,24,27,30,33-heptaenoyl]oxy-3-octanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

Lnape 24:0/N-22:3

C51H96NO8P (881.6873185999999)

Lnape 26:2/N-20:1

C51H96NO8P (881.6873185999999)

Lnape 20:0/N-26:3

C51H96NO8P (881.6873185999999)

Lnape 20:2/N-26:1

C51H96NO8P (881.6873185999999)

Lnape 24:1/N-22:2

C51H96NO8P (881.6873185999999)

Lnape 20:3/N-26:0

C51H96NO8P (881.6873185999999)

Lnape 22:2/N-24:1

C51H96NO8P (881.6873185999999)

Lnape 24:3/N-22:0

C51H96NO8P (881.6873185999999)

Lnape 22:1/N-24:2

C51H96NO8P (881.6873185999999)

Lnape 26:0/N-20:3

C51H96NO8P (881.6873185999999)

Lnape 26:1/N-20:2

C51H96NO8P (881.6873185999999)

Lnape 22:0/N-24:3

C51H96NO8P (881.6873185999999)

Lnape 26:3/N-20:0

C51H96NO8P (881.6873185999999)

Lnape 22:3/N-24:0

C51H96NO8P (881.6873185999999)

Lnape 24:2/N-22:1

C51H96NO8P (881.6873185999999)

Lnape 20:1/N-26:2

C51H96NO8P (881.6873185999999)

2-[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-2-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-[(Z)-icos-11-enoyl]oxy-2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[2-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-3-octadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-hexadecanoyloxy-2-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-[(Z)-hexadec-9-enoyl]oxy-2-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-tetradecanoyloxy-2-[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-dodecanoyloxy-2-[(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-decanoyloxy-2-[(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[2-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-docos-13-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

2-[3-[(Z)-tetradec-9-enoyl]oxy-2-[(12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-12,15,18,21,24,27-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H91NO8 (881.6744326)

HexCer 28:1;3O(FA 17:1)

C51H95NO10 (881.695561)

HexCer 28:2;3O(FA 17:0)

C51H95NO10 (881.695561)

HexCer 29:1;3O(FA 16:1)

C51H95NO10 (881.695561)

HexCer 30:2;3O(FA 15:0)

C51H95NO10 (881.695561)

HexCer 30:1;3O(FA 15:1)

C51H95NO10 (881.695561)

HexCer 29:2;3O(FA 16:0)

C51H95NO10 (881.695561)

HexCer 27:3;3O/18:0;(2OH)

C51H95NO10 (881.695561)

HexCer 31:3;3O/14:0;(2OH)

C51H95NO10 (881.695561)

HexCer 26:3;3O/19:0;(2OH)

C51H95NO10 (881.695561)

HexCer 18:3;3O/27:0;(2OH)

C51H95NO10 (881.695561)

HexCer 24:3;3O/21:0;(2OH)

C51H95NO10 (881.695561)

HexCer 29:3;3O/16:0;(2OH)

C51H95NO10 (881.695561)

HexCer 30:3;3O/15:0;(2OH)

C51H95NO10 (881.695561)

HexCer 23:3;3O/22:0;(2OH)

C51H95NO10 (881.695561)

HexCer 32:2;3O/13:1;(2OH)

C51H95NO10 (881.695561)

HexCer 22:3;3O/23:0;(2OH)

C51H95NO10 (881.695561)

HexCer 32:3;3O/13:0;(2OH)

C51H95NO10 (881.695561)

HexCer 33:3;3O/12:0;(2OH)

C51H95NO10 (881.695561)

HexCer 21:3;3O/24:0;(2OH)

C51H95NO10 (881.695561)

HexCer 13:1;3O/32:2;(2OH)

C51H95NO10 (881.695561)

HexCer 33:2;3O/12:1;(2OH)

C51H95NO10 (881.695561)

HexCer 19:3;3O/26:0;(2OH)

C51H95NO10 (881.695561)

HexCer 28:3;3O/17:0;(2OH)

C51H95NO10 (881.695561)

HexCer 31:2;3O/14:1;(2OH)

C51H95NO10 (881.695561)

HexCer 25:3;3O/20:0;(2OH)

C51H95NO10 (881.695561)

HexCer 20:3;3O/25:0;(2OH)

C51H95NO10 (881.695561)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexacos-15-enoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propan-2-yl] henicosanoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] (Z)-nonadec-9-enoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] (Z)-henicos-11-enoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] (Z)-octacos-17-enoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] nonadecanoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentacosoxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] tricosanoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] (Z)-hexacos-15-enoate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptacosoxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C52H100NO7P (881.723702)

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[3-[(Z)-hexadec-9-enoxy]-2-[(17Z,20Z)-octacosa-17,20-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-docosoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[3-icosoxy-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-[(Z)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-docosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[3-[(Z)-hexacos-15-enoxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[[2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[[2-hexacosanoyloxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-tetracosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[hydroxy-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-[(Z)-tetracos-13-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[2-[(Z)-icos-11-enoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[[2-[(Z)-hexacos-15-enoyl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-octacosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-octadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[3-hexacosoxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[2-icosanoyloxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(Z)-octacos-17-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[[3-[(Z)-hexacos-15-enoxy]-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[[3-hexacosoxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(Z)-octacos-17-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[[2-docosanoyloxy-3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[hydroxy-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-[(Z)-tetracos-13-enoxy]propoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[hydroxy-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-tetracosoxypropoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[hydroxy-[2-icosanoyloxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(Z)-docos-13-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[3-[(Z)-icos-11-enoxy]-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-[(Z)-tetracos-13-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-[(Z)-docos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[hydroxy-[3-icosoxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[2-hexadecanoyloxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-docos-13-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[[3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-2-octadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

2-amino-3-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-octacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

2-amino-3-[hydroxy-[3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]-2-tetracosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C50H92NO9P (881.6509351999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (16Z,19Z,22Z)-triaconta-16,19,22-trienoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (21Z,24Z)-dotriaconta-21,24-dienoate

C51H96NO8P (881.6873185999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] (Z)-octacos-17-enoate

C51H96NO8P (881.6873185999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] (Z)-triacont-19-enoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (18Z,21Z,24Z)-dotriaconta-18,21,24-trienoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosanoyloxypropan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C51H96NO8P (881.6873185999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] octacosanoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosanoyloxypropan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (20Z,23Z,26Z)-tetratriaconta-20,23,26-trienoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropan-2-yl] (19Z,22Z)-triaconta-19,22-dienoate

C51H96NO8P (881.6873185999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropyl] triacontanoate

C51H96NO8P (881.6873185999999)

AHexCer (O-14:0)17:1;2O/14:1;O

C51H95NO10 (881.695561)

AHexCer (O-14:1)17:1;2O/14:0;O

C51H95NO10 (881.695561)

Cer 16:0;2O/20:6;(3OH)(FA 22:6)

C58H91NO5 (881.6896876)

Cer 14:0;2O/22:6;(3OH)(FA 22:6)

C58H91NO5 (881.6896876)

Cer 18:0;2O/20:6;(3OH)(FA 20:6)

C58H91NO5 (881.6896876)

Cer 16:0;2O/22:6;(3OH)(FA 20:6)

C58H91NO5 (881.6896876)

Lpc 44:3-SN1

C52H100NO7P (881.723702)

4-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

HexCer 14:2;3O/31:1;(2OH)

C51H95NO10 (881.695561)

HexCer 17:2;3O/28:1;(2OH)

C51H95NO10 (881.695561)

HexCer 22:2;3O/23:1;(2OH)

C51H95NO10 (881.695561)

HexCer 25:2;3O/20:1;(2OH)

C51H95NO10 (881.695561)

HexCer 21:1;3O/24:2;(2OH)

C51H95NO10 (881.695561)

HexCer 27:2;3O/18:1;(2OH)

C51H95NO10 (881.695561)

HexCer 30:2;3O/15:1;(2OH)

C51H95NO10 (881.695561)

HexCer 24:2;3O/21:1;(2OH)

C51H95NO10 (881.695561)

HexCer 15:1;3O/30:2;(2OH)

C51H95NO10 (881.695561)

HexCer 18:2;3O/27:1;(2OH)

C51H95NO10 (881.695561)

HexCer 19:2;3O/26:1;(2OH)

C51H95NO10 (881.695561)

HexCer 23:1;3O/22:2;(2OH)

C51H95NO10 (881.695561)

HexCer 23:2;3O/22:1;(2OH)

C51H95NO10 (881.695561)

HexCer 26:2;3O/19:1;(2OH)

C51H95NO10 (881.695561)

HexCer 17:1;3O/28:2;(2OH)

C51H95NO10 (881.695561)

HexCer 20:2;3O/25:1;(2OH)

C51H95NO10 (881.695561)

HexCer 15:2;3O/30:1;(2OH)

C51H95NO10 (881.695561)

HexCer 25:1;3O/20:2;(2OH)

C51H95NO10 (881.695561)

HexCer 29:1;3O/16:2;(2OH)

C51H95NO10 (881.695561)

HexCer 16:2;3O/29:1;(2OH)

C51H95NO10 (881.695561)

HexCer 21:2;3O/24:1;(2OH)

C51H95NO10 (881.695561)

HexCer 27:1;3O/18:2;(2OH)

C51H95NO10 (881.695561)

HexCer 29:2;3O/16:1;(2OH)

C51H95NO10 (881.695561)

HexCer 19:1;3O/26:2;(2OH)

C51H95NO10 (881.695561)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] heptacosanoate

C52H100NO7P (881.723702)

[2-[(Z)-hexacos-15-enoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[2-docosanoyloxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[2-hexacosanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H100NO7P (881.723702)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] pentacosanoate

C52H100NO7P (881.723702)

[3-nonanoyloxy-2-[(20Z,23Z,26Z)-tetratriaconta-20,23,26-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] hexacosanoate

C51H96NO8P (881.6873185999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxypropyl] (Z)-tetracos-13-enoate

C51H96NO8P (881.6873185999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] (Z)-hexacos-15-enoate

C51H96NO8P (881.6873185999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxypropyl] tetracosanoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoyl]oxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoyl]oxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C51H96NO8P (881.6873185999999)

[3-heptadecanoyloxy-2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(16Z,19Z,22Z)-triaconta-16,19,22-trienoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[3-nonadecanoyloxy-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(19Z,22Z)-triaconta-19,22-dienoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(18Z,21Z,24Z)-dotriaconta-18,21,24-trienoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(17Z,20Z)-octacosa-17,20-dienoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (22Z,25Z,28Z)-hexatriaconta-22,25,28-trienoate

C51H96NO8P (881.6873185999999)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-henicos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-henicosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[3-[(Z)-heptadec-9-enoyl]oxy-2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[3-heptacosanoyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[3-[(Z)-nonadec-9-enoyl]oxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[3-[(Z)-docos-13-enoyl]oxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(Z)-hexacos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

plasmenyl-PC 44:2

C52H100NO7P (881.723702)

4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2S)-2-[(E)-heptadec-9-enoyl]oxy-3-[(5E,9E)-hexacosa-5,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-11-enoyl]oxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C51H96NO8P (881.6873185999999)

4-[2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-3-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-2-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5E,8E)-icosa-5,8-dienoyl]oxypropan-2-yl] (E)-hexacos-5-enoate

C51H96NO8P (881.6873185999999)

4-[3-icosanoyloxy-2-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-docosanoyloxy-3-[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxy-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

4-[2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(E)-pentacos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-2-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropan-2-yl] hexacosanoate

C51H96NO8P (881.6873185999999)

4-[3-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxy-2-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[(2R)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

4-[3-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxy-2-pentacosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[(2R)-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

4-[3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-2-[(E)-pentacos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(E)-henicos-9-enoyl]oxy-2-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropan-2-yl] (E)-hexacos-5-enoate

C51H96NO8P (881.6873185999999)

4-[3-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-2-[(E)-tetracos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-3-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxy-2-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,8E)-icosa-5,8-dienoyl]oxypropyl] (E)-hexacos-5-enoate

C51H96NO8P (881.6873185999999)

4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(E)-icos-11-enoyl]oxy-2-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-2-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[(2R)-2-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

4-[2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropyl] hexacosanoate

C51H96NO8P (881.6873185999999)

4-[3-[(E)-hexacos-11-enoyl]oxy-2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-13-enoyl]oxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C51H96NO8P (881.6873185999999)

4-[2-icosanoyloxy-3-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-3-[(E)-tetracos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(13E,16E)-docosa-13,16-dienoyl]oxypropyl] (E)-tetracos-15-enoate

C51H96NO8P (881.6873185999999)

4-[3-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropan-2-yl] hexacosanoate

C51H96NO8P (881.6873185999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13E,16E)-docosa-13,16-dienoyl]oxypropan-2-yl] (E)-tetracos-15-enoate

C51H96NO8P (881.6873185999999)

4-[2-[(E)-docos-11-enoyl]oxy-3-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(E)-henicos-9-enoyl]oxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-2-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-2-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(E)-hexacos-11-enoyl]oxy-3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(E)-icos-11-enoyl]oxy-3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2R)-3-[(E)-heptadec-9-enoyl]oxy-2-[(5E,9E)-hexacosa-5,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H96NO8P (881.6873185999999)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-11-enoyl]oxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C51H96NO8P (881.6873185999999)

4-[2-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxy-3-pentacosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-henicosanoyloxy-2-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[2-henicosanoyloxy-3-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropyl] hexacosanoate

C51H96NO8P (881.6873185999999)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-13-enoyl]oxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C51H96NO8P (881.6873185999999)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropyl] (E)-hexacos-5-enoate

C51H96NO8P (881.6873185999999)

4-[2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-[(E)-docos-11-enoyl]oxy-2-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

4-[3-docosanoyloxy-2-[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C55H95NO7 (881.710816)

2-[[(E)-2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenoyl]amino]-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-10,13,16,19,22,25,28,31-octaenoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[hydroxy-[3-hydroxy-2-[[(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-10,13,16,19,22,25,28,31,34,37-decaenoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[[3,4-dihydroxy-2-[[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoyl]amino]octadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H98N2O7P+ (881.7111268000001)

2-[[(E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]amino]octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[[2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenoyl]amino]-3-hydroxydodecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[hydroxy-[(E)-3-hydroxy-2-[[(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-11,14,17,20,23,26,29,32,35-nonaenoyl]amino]dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[[(4E,8E)-2-[[(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-12,15,18,21,24,27,30,33-octaenoyl]amino]-3-hydroxydodeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[[(4E,8E,12E)-2-[[(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoyl]amino]-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[[(E)-2-[[(4E,7Z)-hexadeca-4,7-dienoyl]amino]-3-tetradecanoyloxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H98N2O7P+ (881.7111268000001)

2-[[(4E,8E,12E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[hydroxy-[(E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[hydroxy-[(E)-3-hydroxy-2-[[(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-13,16,19,22,25,28,31,34,37-nonaenoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]amino]octadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[[(E)-3-[(Z)-hexadec-7-enoyl]oxy-2-[[(Z)-tetradec-9-enoyl]amino]hexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H98N2O7P+ (881.7111268000001)

2-[[(E)-3-[(4E,7Z)-hexadeca-4,7-dienoyl]oxy-2-(tetradecanoylamino)hexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H98N2O7P+ (881.7111268000001)

2-[[(4E,8E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-8,11,14,17,20,23,26,29-octaenoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[[(E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-[(Z)-tetradec-9-enoyl]oxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H98N2O7P+ (881.7111268000001)

2-[hydroxy-[(E)-2-[[(Z)-tetradec-9-enoyl]amino]-3-[(Z)-tetradec-9-enoyl]oxyoctadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C51H98N2O7P+ (881.7111268000001)

2-[[(8E,12E)-3,4-dihydroxy-2-[[(17Z,20Z)-octacosa-17,20-dienoyl]amino]octadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H98N2O7P+ (881.7111268000001)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]amino]icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[hydroxy-[3-hydroxy-2-[[(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenoyl]amino]decoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

2-[[(E)-3,4-dihydroxy-2-[[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]amino]octadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H98N2O7P+ (881.7111268000001)

2-[[(8E,12E,16E)-3,4-dihydroxy-2-[[(Z)-octacos-17-enoyl]amino]octadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H98N2O7P+ (881.7111268000001)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoyl]amino]tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H90N2O6P+ (881.653615)

PC(O-22:1(13Z)/22:2(13Z,16Z))

C52H100NO7P (881.723702)

PC(O-22:0/22:3(10Z,13Z,16Z))

C52H100NO7P (881.723702)

PE-NMe2(22:2(13Z,16Z)/22:1(13Z))

C51H96NO8P (881.6873185999999)

PE(22:2(13Z,16Z)/24:1(15Z))

C51H96NO8P (881.6873185999999)

phosphatidylcholine O-44:3

C52H100NO7P (881.723702)

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 44 carbons and 3 double bonds.

1-docosyl-2-[(10Z,13Z,16Z)-docosatrienoyl]-sn-glycero-3-phosphocholine

C52H100NO7P (881.723702)

A phosphatidylcholine O-44:3 in which the alkyl and acyl groups specified at positions 1 and 2 are docosyl and (10Z,13Z,16Z)-docosatrienoyl respectively.

MePC(43:3)

C52H100NO7P (881.723702)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

PC(43:3)

C51H96NO8P (881.6873185999999)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 41:2;O2

C51H95NO10 (881.695561)

DGCC 44:7

C54H91NO8 (881.6744326)

DGTS 44:7;O

C54H91NO8 (881.6744326)

DGTS 45:6

C55H95NO7 (881.710816)

PC O-18:1/26:2

C52H100NO7P (881.723702)

PC O-18:2/26:1

C52H100NO7P (881.723702)

PC O-20:0/22:5;O2

C50H92NO9P (881.6509351999999)

PC O-20:2/24:1

C52H100NO7P (881.723702)

PC O-22:0/22:3

C52H100NO7P (881.723702)

PC O-22:1/22:2

C52H100NO7P (881.723702)

PC O-22:2/22:1

C52H100NO7P (881.723702)

PC O-42:5;O2

C50H92NO9P (881.6509351999999)

PC P-18:0/26:2

C52H100NO7P (881.723702)

PC P-18:0/26:2 or PC O-18:1/26:2

C52H100NO7P (881.723702)

PC P-18:1/26:1

C52H100NO7P (881.723702)

PC P-18:1/26:1 or PC O-18:2/26:1

C52H100NO7P (881.723702)

PC P-20:1/24:1

C52H100NO7P (881.723702)

PC P-20:1/24:1 or PC O-20:2/24:1

C52H100NO7P (881.723702)

PC P-22:0/22:2

C52H100NO7P (881.723702)

PC P-22:0/22:2 or PC O-22:1/22:2

C52H100NO7P (881.723702)

PC P-22:1/22:1

C52H100NO7P (881.723702)

PC P-22:1/22:1 or PC O-22:2/22:1

C52H100NO7P (881.723702)

PC P-44:2

C52H100NO7P (881.723702)

PC P-44:2 or PC O-44:3

C52H100NO7P (881.723702)

PC 20:0/22:4;O

C50H92NO9P (881.6509351999999)

PC 22:0/20:4;O

C50H92NO9P (881.6509351999999)

PC 22:1/20:3;O

C50H92NO9P (881.6509351999999)

PC 22:2/20:2;O

C50H92NO9P (881.6509351999999)

PC 42:4;O

C50H92NO9P (881.6509351999999)

PC 17:1_26:2

C51H96NO8P (881.6873185999999)

PC 17:2_26:1

C51H96NO8P (881.6873185999999)

PC 18:3_25:0

C51H96NO8P (881.6873185999999)

PC 20:3_23:0

C51H96NO8P (881.6873185999999)

PC 43:3

C51H96NO8P (881.6873185999999)

LNAPE 45:4;O

C50H92NO9P (881.6509351999999)

LNAPE 46:3

C51H96NO8P (881.6873185999999)

PE 18:3_28:0

C51H96NO8P (881.6873185999999)

PE 20:1_26:2

C51H96NO8P (881.6873185999999)

PE 20:2_26:1

C51H96NO8P (881.6873185999999)

PE 20:3_26:0

C51H96NO8P (881.6873185999999)

PE 22:2_24:1

C51H96NO8P (881.6873185999999)

PE 46:3

C51H96NO8P (881.6873185999999)

PS O-18:2/26:2

C50H92NO9P (881.6509351999999)

PS O-20:0/24:4

C50H92NO9P (881.6509351999999)

PS O-22:0/22:4

C50H92NO9P (881.6509351999999)

PS O-22:2/22:2

C50H92NO9P (881.6509351999999)

PS O-44:4

C50H92NO9P (881.6509351999999)

PS P-18:1/26:2

C50H92NO9P (881.6509351999999)